# OnCo record famicordtx (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/famicordtx/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "famicordtx" ;
  schema:name "FamiCordTx"@en ;
  schema:alternateName "FamiCordTx S.A."@en ;
  schema:description "FamiCordTx is a Polish company developing cell and gene therapies. Its first CAR-T therapy, which re-engineers a patient's own immune cells to attack CD19 on cancer cells, is in an early trial in leukaemia and lymphoma."@en ;
  schema:url <https://onco.cc/companies/famicordtx/>, <https://famicordtx.com/> ;
  schema:dateModified "2026-10-29"^^xsd:date ;
  schema:citation <https://famicordtx.com/>, <https://clinicaltrials.gov/study/NCT06593145> ;
  schema:addressCountry "PL" ;
  onco:cancers <https://onco.cc/cancers/all-leukemia/>, <https://onco.cc/cancers/mantle-cell-lymphoma/>, <https://onco.cc/cancers/dlbcl/> ;
  onco:sections <https://onco.cc/fronts/cell-therapy/> ;
  onco:technologies <https://onco.cc/technologies/car-t/> ;
  onco:targets <https://onco.cc/targets/cd19/> .